Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSXV/RX stock hub

TSXV/RX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/RXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

168.1M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/RX

In the news

Latest news · TSXV/RX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.6

P25 11P50 15.6P75 25.4

Trailing P/E18.8

P25 7.4P50 15.6P75 34.3

ROE23.6

P25 -121.5P50 -40.9P75 0.5

ROIC54

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/RX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

CAD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 140.3M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA0906901081
Last refreshed	2026-05-10
Market cap	CAD 168.1M
Price	CAD 14.7
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	tsxv/RX
Website	https://www.biosyent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.36%
EV Earnings	15.57x
EV/EBIT	12.54x
EV/EBITDA	11.67x
EV/FCF	15.65x
EV/Sales	3.26x
FCF yield	5.33%
Forward P/E	15.64x
P/B ratio	4.06x
P/E ratio	18.77x
P/S ratio	3.91x
PE Ratio10 Y	20.01x
PE Ratio3 Y	16.29x
PE Ratio5 Y	17.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26%
EBITDA Margin	27.63%
FCF margin	20.83%
Gross margin	76.57%
Gross Profit	CAD 33M
Gross Profit Growth	18.33%
Gross Profit Growth Q	4.07%
Gross Profit Growth3 Y	12.98%
Gross Profit Growth5 Y	13.6%
Net Income	CAD 9M
Net Income Growth	23.96%
Net Income Growth Q	23.47%
Net Income Growth Quarters	5%
Net Income Growth Years	3%
Net Income Growth3 Y	18.19%
Net Income Growth5 Y	18.88%
Pretax Margin	27.94%
Profit Margin	20.93%
Profitable Years	16
ROA	15.41
Roa5y	13.27
ROCE	26.51
ROE	23.57
Roe5y	20.35
ROIC	54
Roic5y	83.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.72%
Cagr15y	43.45%
Cagr1y	37.09%
Cagr20y	27.86%
Cagr3y	26.86%
Cagr5y	15%
EPS Growth	27.11
EPS Growth Q	25.52
EPS Growth Quarters	5
EPS Growth Years	3
EPS Growth3 Y	21.64
EPS Growth5 Y	21.98
FCF Growth	3.92%
FCF Growth Q	33.15%
FCF Growth3 Y	22.31%
FCF Growth5 Y	5.44%
OCF Growth	3.99%
OCF Growth Q	33.23%
OCF Growth10 Y	12.35%
OCF Growth3 Y	22.1%
OCF Growth5 Y	5.5%
Revenue Growth	22.9x
Revenue Growth Q	9.95x
Revenue Growth Quarters	11x
Revenue Growth Years	3x
Revenue Growth3 Y	15.52x
Revenue Growth5 Y	14.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.95
Assets	CAD 49.4M
Cash	CAD 28.7M
Current Assets	CAD 39.8M
Current Liabilities	CAD 7.2M
Debt	CAD 841,104
Debt EBITDA	CAD 0.07
Debt Equity	CAD 0.02
Debt FCF	CAD 0.09
Equity	CAD 41.5M
Interest Coverage	226.8
Liabilities	CAD 8M
Long Term Assets	CAD 9.6M
Long Term Liabilities	CAD 758,345
Net Cash	CAD 27.8M
Net Cash By Market Cap	CAD 16.54
Net Cash Growth	86.61%
Net Debt EBITDA	CAD -2.34
Net Debt Equity	CAD -0.67
Net Debt FCF	CAD -3.1
Tangible Book Value	CAD 36.8M
Tangible Book Value Per Share	CAD 3.27
WACC	7.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.51
Inventory Turnover	1.72
Net Working Capital	CAD 4.1M
Quick ratio	4.59
Working Capital	CAD 32.6M
Working Capital Turnover	CAD 1.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.55%
Dividend Growth	10.81%
Dividend Growth Years	4%
Dividend per share	CAD 0.22
Dividend Years	5
Dividend Yield	1.5%
Ex Div Date	2026-02-27
Last Dividend	CAD 0.06
Payout Frequency	Quarterly
Payout Ratio	24.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	130.73%
1Y total return	37.06%
200-day SMA	12.84
3Y total return	104.19%
50-day SMA	15.01
50-day SMA vs 200-day SMA	50over200
5Y total return	101.15%
All Time High	15.8
All Time High Change	-6.96%
All Time High Date	2026-02-24
All Time Low	0.01
All Time Low Change	146,900%
All Time Low Date	2001-12-13
ATR	0.32
Beta	0.64
Beta1y	1.06
Beta2y	0.67
Ch YTD	15.48
High	14.76
High52	15.8
High52 Date	2026-02-26
High52ch	-6.96%
Low	14.7
Low52	10.65
Low52 Date	2025-11-20
Low52ch	38.03%
Ma50ch	-2.08%
Price vs 200-day SMA	14.51%
RSI	48.99
RSI Monthly	68.5
RSI Weekly	59.13
Sharpe ratio	1.12x
Sortino ratio	2.28
Total Return	4.05%
Tr YTD	15.89
Tr15y	22,314%
Tr1m	2.01%
Tr1w	2.73%
Tr3m	15.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 11.2M
Operating Income Growth	21.89
Operating Income Growth Q	-8.63
Operating Income Growth3 Y	17.04
Operating Income Growth5 Y	17.35
Operating margin	26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,227,500%
Net Borrowing	-196,627
Shares Insiders	9.82%
Shares Institutions	19.5%
Shares Out	11,438,318
Shares Qo Q	0.05%
Shares Yo Y	-2.55%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 8.3M
Average Volume	4,899.65x
Bv Per Share	3.68
CAPEX	CAD -39,669
Ch10y	116.2
Ch15y	20,900
Ch1m	2.01
Ch1w	2.73
Ch1y	34.86
Ch20y	12,682.6
Ch3m	14.84
Ch3y	93.42
Ch5y	88.46
Ch6m	34
Change	0.41%
Change From Open	-0.41
Close	14.64
Days Gap	0.82
Depreciation Amortization	700,345
Dollar Volume	13,435.8
Earnings Date	2026-05-14
EBIT	CAD 11.2M
EBITDA	CAD 11.9M
EPS	CAD 0.78
F Score	5
FCF	CAD 9M
FCF EV Yield	6.39x
FCF Per Share	CAD 0.78
Financing CF	-3,407,391
Fiscal Year End	December
Founded	2,006
Graham Number	8.05348
Graham Upside	-45.21
Income Tax	CAD 3M
Investing CF	4,092,668
Is Primary Listing	1
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Lynch Fair Value	CAD 14.78
Lynch Upside	0.58
Ma150	13.23
Ma150ch	11.15%
Ma20	14.75
Ma20ch	-0.37%
Net CF	9,681,310
Next Earnings Date	2026-05-14
Open	14.76
P FCF Ratio	18.75
P OCF Ratio	18.66
Payment Date	2026-03-13
Position In Range	0
Ppne	944,433
Price Date	2026-05-08
Price EBITDA	CAD 14.14
Ptbv Ratio	4.57
Relative Volume	0.19x
Revenue	43,051,983x
SBC By Revenue	1.45x
Share Based Comp	624,613
Tax By Revenue	7.01x
Tax Rate	25.09%
Tr20y	13,543.33%
Tr6m	35.04%
Volume	914
Z Score	13.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TSXV/RX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.5%

$0.22 annual per share

Payout ratio

+25.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

4 consecutive years of growth

Total shareholder yield

+4.0%

Next ex-dividend date: 2026-02-27

Performance

TSXV/RX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/RX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.5%

Share of float held by funds and institutions

Insider ownership

+9.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.6%

Negative means the company is buying back shares.

Technical

TSXV/RX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.0

Neutral momentum band

Price vs 200-day MA

+14.5%

50/200-day relationship not available

Beta (5Y)

0.64

Less volatile than the market

Sharpe ratio

1.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/RX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/RX stock rating?

tsxv/RX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/RX analysis?

The full report lives at /stocks/tsxv/RX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/RX?

The latest report frames tsxv/RX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/RX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.